Amalgamated Bank’s Mersana Therapeutics MRSN Stock Holding History

Amalgamated Bank’s Portfolio MRSN Stock Details MRSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-151	Closed	-$1K	–	3090
2025 Q1	$1K	Hold	151	–	–	﹤0.01%	2920
2024 Q4	$5K	Hold	151	–	–	﹤0.01%	2738
2024 Q3	$7K	Hold	151	–	–	﹤0.01%	2629
2024 Q2	$8K	Hold	151	–	–	﹤0.01%	2564
2024 Q1	$17K	Sell	151 -320	-68%	-$31.8K	﹤0.01%	2203
2023 Q4	$27K	Sell	471 -36	-7%	-$1.45K	﹤0.01%	2518
2023 Q3	$16K	Hold	507	–	–	﹤0.01%	2752
2023 Q2	$42K	Buy	507 +131	+35%	+$19.2K	﹤0.01%	2398
2023 Q1	$39K	Sell	376 -97	-21%	-$13.6K	﹤0.01%	2405
2022 Q4	$69K	Buy	473 +15	+3%	+$2.54K	﹤0.01%	2296
2022 Q3	$77K	Buy	458 +13	+3%	+$2.11K	﹤0.01%	2269
2022 Q2	$51K	Buy	445 +13	+3%	+$1.22K	﹤0.01%	2474
2022 Q1	$43K	Sell	432 -33	-7%	-$3.85K	﹤0.01%	2547
2021 Q4	$72K	Sell	465 -9	-2%	-$1.75K	﹤0.01%	2090
2021 Q3	$112K	Sell	474 -7	-1%	-$2.04K	﹤0.01%	2067
2021 Q2	$163K	Buy	+481	New	+$182K	﹤0.01%	2062
2021 Q1	–	Sell	-333	Closed	-$222K	–	1616
2020 Q4	$222K	Buy	+333	New	+$185K	0.01%	1394

Other funds holding MRSN

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Schonfeld Strategic Advisors New York $12.3B AUM 37.17% 1-Year Est. Return

AQR Capital Management

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Silverarc Capital Management Boston, Massachusetts $849M AUM 470.8% 1-Year Est. Return

Acadian Asset Management

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return